Amgen (AMGN) Finished Goods (2013 - 2017)

Amgen has reported Finished Goods for 5 years, with the latest figure at $1.1 billion in Q2 2017.

• On a quarterly basis, Finished Goods changed N/A year-over-year to $1.1 billion in Q2 2017; TTM through Jun 2017 was $1.1 billion, a N/A change from a year earlier, with the FY2016 full-year figure at $912.0 million, up 29.36% from the prior year.
• Finished Goods was $1.1 billion for Q2 2017 at Amgen, down from $1.2 billion in the prior quarter.
• The five-year high for Finished Goods was $1.2 billion in Q1 2017, with the low at $705.0 million in Q4 2015.
• Average Finished Goods over 5 years is $920.5 million, with a median of $914.0 million recorded in 2014.
• The sharpest annual moves came in 2015 and 2017: Finished Goods dropped 21.49% in 2015, then surged 48.02% in 2017.
• Over 5 years, Finished Goods stood at $738.0 million in 2013, then climbed by 21.68% to $898.0 million in 2014, then declined by 21.49% to $705.0 million in 2015, then climbed by 29.36% to $912.0 million in 2016, then gained by 21.27% to $1.1 billion in 2017.
• The last three Finished Goods figures came in at $1.1 billion (Q2 2017), $1.2 billion (Q1 2017), and $912.0 million (Q4 2016), per Business Quant data.